Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. signed the share transfer agreement to acquire a 51% stake in Zhongzhu Zhongke Stem Cell Gene Technology Co., Ltd. from Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) for CNY 3 million on August 24, 2021. Post transaction, Zhongzhu Healthcare Holding will not have any stake in Zhongzhu Zhongke Stem Cell Gene Technology Co., Ltd. Zhongzhu Zhongke Stem Cell Gene Technology Co., Ltd. reported total assets of CNY 6.9 million, liabilities of CNY 0.006 million, net assets of CNY 6.9 million, revenue of CNY 0.59 million and net loss of CNY 1.96 million for the year ended December 31, 2020 and total assets of CNY 6.96 million, liabilities of CNY 1.4 million and net assets of CNY 5.6 million for the year ended June 30, 2021. Transaction is approved by board of Zhongzhu Healthcare Holding Co.,Ltd.